Expertise in
14
conditions

Dr. Afsaneh A. Alavi

Dermatology
Mayo Building And Gonda Building
200 1st St Sw, 
Rochester, MN 
 (360.6 mi)
Expertise in
14
conditions
Mayo Building And Gonda Building
200 1st St Sw, 
Rochester, MN 
 (360.6 mi)
OverviewInsuranceLocationsClinical Research

Overview

Afsaneh Alavi is a Dermatologist in Rochester, Minnesota. Dr. Alavi is highly rated in 14 conditions, according to our data. Her top areas of expertise are Hidradenitis Suppurativa, Pyoderma Gangrenosum, Livedo Reticularis, and Comedones.

Her clinical research consists of co-authoring 249 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in MN
Hospital Affiliations
Mayo Clinic Health System In Red Wing
Mayo Clinic Hospital Rochester
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Medica
  •  Humana

Locations

Mayo Building and Gonda Building
200 1st St Sw, Rochester, MN 55905

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
Enrollment Status: Terminated
Publish Date: August 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Dose-Escalation, Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
A Phase 2, Dose-Escalation, Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Enrollment Status: Completed
Publish Date: September 26, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials

255 Total Publications

Secukinumab in bio-experienced patients with moderate-to-severe hidradenitis suppurativa from a single center: an observational retrospective study.
Secukinumab in bio-experienced patients with moderate-to-severe hidradenitis suppurativa from a single center: an observational retrospective study.
Journal: International journal of dermatology
Published: September 05, 2024
Similar Doctors
Expertise in
22
conditions
Dr. Jerry D. Brewer
Dermatology
Expertise in
22
conditions
Dr. Jerry D. Brewer
Dermatology

Mayo Building And Gonda Building

200 1st St Sw, 
Rochester, MN 
507-284-2511
Languages Spoken:
English
See accepted insurances

Jerry Brewer is a Dermatologist in Rochester, Minnesota. Dr. Brewer is highly rated in 22 conditions, according to our data. His top areas of expertise are Extramammary Paget Disease, Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Vulvectomy, and Penectomy.

Expertise in
21
conditions
Dr. Megha M. Tollefson
Dermatology | Pediatrics
Expertise in
21
conditions
Dr. Megha M. Tollefson
Dermatology | Pediatrics

Mayo Building And Gonda Building

200 1st St Sw, 
Rochester, MN 
507-284-2511
Languages Spoken:
English
See accepted insurances

Megha Tollefson is a Dermatologist and a Pediatrics provider in Rochester, Minnesota. Dr. Tollefson is highly rated in 21 conditions, according to our data. Her top areas of expertise are Klippel-Trenaunay Syndrome, Progressive Hemifacial Atrophy, Hemangioma, and Vascular Birthmark.

Expertise in
9
conditions
Dr. Rochelle R. Torgerson
Dermatology
Expertise in
9
conditions
Dr. Rochelle R. Torgerson
Dermatology

Mayo Building And Gonda Building

200 1st St Sw, 
Rochester, MN 
507-284-2511
Languages Spoken:
English
See accepted insurances

Rochelle Torgerson is a Dermatologist in Rochester, Minnesota. Dr. Torgerson is highly rated in 9 conditions, according to our data. Her top areas of expertise are Lichen Sclerosus, Lichen Planus, Autosomal Recessive Hypotrichosis, and Burning Mouth Syndrome.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile